Hepatoprotective effects of IL-22 on fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide in mice

Cytokine

Volumn 56, Issue 2, 2011, Pages 174-179

  Xing, Wei wei ^a   Zou, Min ji ^a   Liu, Shen ^a   Xu, Tao ^a   Gao, Jie ^a   Wang, Jia xi ^a   Xu, Dong gang ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Apoptosis; Fulminant hepatic failure; Interleukin 22; Oxidative stress; TNF

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; GALACTOSAMINE; GLUTATHIONE; HEME OXYGENASE 1; INTERLEUKIN 10; INTERLEUKIN 22; LIPOPOLYSACCHARIDE; MALONALDEHYDE; MESSENGER RNA; PROTEIN BCL XL; REDOX EFFECTOR FACTOR 1; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; FULMINANT HEPATIC FAILURE; HISTOPATHOLOGY; INNATE IMMUNITY; LIPID PEROXIDATION; LIVER FAILURE; LIVER PROTECTION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TH1 CELL; TH17 CELL; WESTERN BLOTTING;

ALANINE TRANSAMINASE; ANIMALS; BASE SEQUENCE; BCL-X PROTEIN; BILIRUBIN; CASPASE 3; DNA PRIMERS; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; GALACTOSAMINE; GLUTATHIONE; HEME OXYGENASE-1; INTERLEUKIN-1; INTERLEUKINS; LIPOPOLYSACCHARIDES; LIVER; LIVER FAILURE, ACUTE; MALE; MALONDIALDEHYDE; MICE; MICE, INBRED BALB C; PHOSPHORYLATION; RECOMBINANT PROTEINS; STAT3 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 80053308255     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.07.022     Document Type: Article

References (29)

1. Schiodt F.V., Lee W.M. Fulminant liver disease. Clin Liver Dis 2003, 7:331-349.
2. Silverstein R. d-Galactosamine lethality model: scope and limitations. J Endotoxin Res 2004, 10:147-162.
3. Hishinuma I., Nagakawa J., Hirota K., Miyamoto K., Tsukidate K., Yamanaka T.K., et al. Involvement of tumor necrosis factor-alpha in development of hepatic injury in galactosamine-sensitized mice. Hepatology 1990, 12:1187-1191.
4. Nakama T., Hirono S., Moriuchi A., Hasuike S., Nagata K., Hori T., et al. Etoposide prevents apoptosis in mouse liver with d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality. Hepatology 2001, 33:1441-1450.
5. Wang C.C., Cheng P.Y., Peng Y.J., Wu E.S.C., Wei H.P., Yen M.H. Naltrexone protects against lipopolysaccharide/d-galactosamine-induced hepatitis in mice. J Pharmacol Sci 2008, 108:239-247.
6. Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury. J Gastroenterol Hepatol 2000, 15:718-724.
7. Amin A., Hamza A.A. Oxidative stress mediates drug-induced hepatotoxicity in rats: a possible role of DNA fragmentation. Toxicology 2005, 208:367-375.
8. Colonna M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 2009, 31:15-23.
9. Duhen T., Geiger R., Jarrossay D., Lanzavecchia A., Sallusto F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 2009, 10:857-863.
10. Xie M.H., Aggarwal S., Ho W.H., Foster J., Zhang Z., Stinson J., et al. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 2000, 275:31335-31339.
11. Zenewicz L.A., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., Karow M., Flavell R.A. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 2007, 27:647-659.
12. Pan H., Hong F., Radaeva S., Gao B. Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3. Cell Mol Immunol 2004, 1:43-49.
13. Ren X.H.B., Colletti L.M. IL-22 is involved in liver regeneration after hepatectomy. Am J Physiol Gastrointest Liver Physiol 2010, 298:G74-G80.
14. Ki S.H., Park O., Zheng M., Morales-Ibanez O., Kolls J.K., Bataller R., et al. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 2010, 52:1291-1300.
15. Yang L., Zhang Y., Wang L., Fan F., Zhu L., Li Z., et al. Amelioration of high fat diet induced lipogenesis and hepatic steatosis by interleukin-22. J Hepatol 2010, 53:339-347.
16. Cai X., Wang L.H., Wang J.X. Isolation of human interleukin-22 gene and its expression in E. coli. Chinese J Biochem Mol Biol 2003, 2:268-271.
17. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol 1978, 52:302-310.
18. Brehe J.E., Burch H.B. Enzymatic assay for glutathione. Anal Biochem 1976, 74:189-197.
19. Liu L.M., Zhang J.X., Luo J., Guo H.X., Deng H., Chen J.Y., et al. A role of cell apoptosis in lipopolysaccharide (LPS)-induced nonlethal liver injury in d-galactosamine (d-GalN)-sensitized rats. Dig Dis Sci 2008, 53:1316-1324.
20. Zheng Y., Valdez P.A., Danilenko D.M., Hu Y., Sa S.M., Gong Q., et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008, 14:282-289.
21. Wu J., Liu L., Yen R.D., Catana A., Nantz M.H., Zern M.A. Liposome-mediated extracellular superoxide dismutase gene delivery protects against acute liver injury in mice. Hepatology 2004, 40:195-204.
22. Osawa Y., Nagaki M., Banno Y., Yamada Y., Imose M., Nozawa Y., et al. Possible involvement of reactive oxygen species in d-galactosamine-induced sensitization against tumor necrosis factor-alpha-induced hepatocyte apoptosis. J Cell Physiol 2001, 187:374-385.
23. Han D., Hanawa N., Saberi B., Kaplowitz N. Hydrogen peroxide and redox modulation sensitize primary mouse hepatocytes to TNF-induced apoptosis. Free Radic Biol Med 2006, 41:627-639.
24. Wen T., Wu Z.M., Liu Y., Tan Y.F., Ren F., Wu H. Upregulation of heme oxygenase-1 with hemin prevents d-galactosamine and lipopolysaccharide-induced acute hepatic injury in rats. Toxicology 2007, 237:184-193.
25. Otterbein L.E., Soares M.P., Yamashita K., Bach F.H. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 2003, 24:449-455.
26. Ozaki M., Suzuki S., Irani K. Redox factor-1/APE suppresses oxidative stress by inhibiting the rac1 GTPase. FASEB J 2002, 16:889-890.
27. Haga S., Terui K., Zhang H.Q., Enosawa S., Ogawa W., Inoue H., et al. STAT3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest 2003, 112:989-998.
28. Guo L., Haga S., Enosawa S., Naruse K., Harihara Y., Sugawara Y., et al. Improved hepatic regeneration with reduced injury by redox factor-1 in a rat small-sized liver transplant model. Am J Transplant 2004, 4:879-887.
29. Nagalakshmi M.L., Rascle A., Zurawski S., Menon S., de Waal Malefyt R. Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. Int Immunopharmacol 2004, 4:679-691.